Logo image
Methicillin-resistant Staphylococcus aureus clones, Western Australia
Journal article   Open access   Peer reviewed

Methicillin-resistant Staphylococcus aureus clones, Western Australia

G.W. Coombs, J.C. Pearson, F.G. O'Brien, R.J. Murray, W.B. Grubb and K.J. Christiansen
Emerging Infectious Diseases, Vol.12(2), pp.241-247
2006
pdf
methicillin-resistant Staphylococcus aureus clones.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (MRSA) was first reported in Western Australia in the early 1990s from indigenous peoples living in remote areas. Although a statewide policy of screening all hospital patients and staff who have lived outside the state for MRSA has prevented the establishment of multidrug-resistant epidemic MRSA, the policy has not prevented SCCmec type IV and type V MRSA clones from becoming established. Of the 4,099 MRSA isolates analyzed (referred to the Gram-positive Bacteria Typing and Research Unit) from July 2003 to December 2004, 77.5% were community-associated MRSA (CA-MRSA). Using multilocus sequence/staphylococcal chromosome cassette mec typing, 22 CA-MRSA clones were characterized. Of these isolates, 55.5% were resistant to >1 non–β-lactam antimicrobial drug. Five Panton-Valentine leukocidin (PVL)–positive CA-MRSA clones were identified. The emergence of multidrug-resistant CA-MRSA clones and the detection of PVL toxin genes in clones previously reported as PVL negative is a major public health concern.

Details

Metrics

126 File views/ downloads
63 Record Views
Logo image